Last reviewed 2026-08-25
The healing peptides have the largest gap on this site between how impressive the animal research looks and how little human evidence exists. BPC-157 accelerated tendon, ligament, muscle and gut healing across a long series of rodent studies. Almost none of that has been tested in people. This is not the same as saying it does not work — it is saying that nobody has checked, and that a claim resting entirely on rats deserves to be labelled as such.
Recovery is where peptides have their most enthusiastic word-of-mouth following, largely on the strength of BPC-157's animal literature, which is unusually consistent across injury models.
The problem is the translation step. Rodent healing studies have a long history of not reproducing in humans, and BPC-157 has never been through the controlled human trials that would settle it. There is also a regulatory dimension: BPC-157 has been through FDA compounding review and has not been added to the 503A Bulks List, with the agency raising concerns about how well the substance is characterised and about its safety.
If you are weighing this for an actual injury, the honest framing is that you are paying for a promising animal result and an untested human one.
Every entry carries the level of human evidence for this use — not the compound’s approval status for something else.
| Peptide | Evidence for this goal | FDA status | Typical cost/mo |
|---|---|---|---|
| BPC-157 | Animal studies only | Research | $100–$300 |
| TB-500 | Animal studies only | Research | $120–$280 |
| GHK-Cu | Human trials, not approved for this use | Research | $80–$200 |
| KPV | Animal studies only | Research | $80–$250 |
The most searched healing peptide; studied in rodents across tendon, ligament, muscle and gut injury.
The catch: The rodent evidence is extensive and consistent. Controlled human trials are essentially absent, and BPC-157 has not been added to the FDA 503A Bulks List for routine pharmacy compounding, with the agency flagging concerns about how well it is characterised and its safety.
Synthetic fragment related to thymosin beta-4, used for soft tissue repair.
The catch: Thymosin beta-4 itself has been through some human trials in other indications. TB-500 as sold is a fragment, and the healing claims rest on animal work.
Copper peptide with documented roles in wound repair and collagen synthesis.
The catch: The best human evidence on this page, but it concerns skin and wound healing rather than tendon, ligament or joint injury.
Anti-inflammatory tripeptide, used particularly for gut inflammation.
The catch: Animal and cell work only. No human trials support the uses it is sold for.
Nothing here has controlled human trial evidence for injury healing. GHK-Cu comes closest, with real human wound-healing and skin data, though that is skin rather than tendon or ligament.
Combinations people actually run, with the dosing protocol and the evidence framing each one deserves. These are community protocols rather than tested regimens.
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.
BPC-157 requires a prescription and medical supervision. Each service below states that a licensed provider reviews your intake and prescribes through a US compounding pharmacy where appropriate. Those are the companies’ own descriptions of how they operate, not findings of ours. Compounded medications are not FDA-approved, and a consultation does not guarantee a prescription.
Some telehealth links below are affiliate links. If you buy through them, we may earn a commission at no extra cost to you. Commission never affects which products or clinics we list, how they are ordered, or what we say about them — see our editorial policy.
Says a board-certified physician reviews each intake and prescribes through a licensed 503A compounding pharmacy where appropriate, and lists a LegitScript certification. Compounded medications are not FDA-approved.
We are not a clinic and do not prescribe. Listing a service here is not a clinical endorsement of it, and you should confirm licensure and pharmacy sourcing yourself before treatment.
In rodents, consistently and across many injury models. In humans, it has essentially never been tested in a controlled trial. The animal evidence is real and the human evidence is missing, and both halves of that sentence matter.
It is not FDA-approved, and it has not been added to the FDA 503A Bulks List that permits routine compounding by pharmacies, with the agency raising concerns about characterisation and safety. It is also prohibited in sport by WADA. It is widely sold as a research chemical, which means no pharmaceutical manufacturing standard applies.
Both rest on animal data rather than human trials, so any comparison is between two untested options. BPC-157 has the larger animal literature specific to tendon and ligament. Neither has been shown to work in people.
Our directory lists clinics whose own websites show they offer peptide therapy. We verify what each one actually provides rather than taking a listing at face value.
Browse the provider directory